Berry Genomics Co Ltd - Asset Resilience Ratio

Latest as of September 2025: 0.45%

Berry Genomics Co Ltd (000710) has an Asset Resilience Ratio of 0.45% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read 000710 current and long-term liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥10.48 Million

≈ $1.53 Million USD Cash + Short-term Investments

Total Assets

CN¥2.34 Billion

≈ $342.96 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (1997–2024)

This chart shows how Berry Genomics Co Ltd's Asset Resilience Ratio has changed over time. See Berry Genomics Co Ltd net assets for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Berry Genomics Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 000710 stock market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥10.48 Million	0.45%
Total Liquid Assets	CN¥10.48 Million	0.45%

Asset Resilience Insights

Limited Liquidity: Berry Genomics Co Ltd maintains only 0.45% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Berry Genomics Co Ltd Industry Peers by Asset Resilience Ratio

Compare Berry Genomics Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Revvity Inc. NYSE:RVTY	Diagnostics & Research	0.00%
Sonic Healthcare Ltd AU:SHL	Diagnostics & Research	0.13%
Fleury S.A. SA:FLRY3	Diagnostics & Research	16.19%
Shanghai Labway Clinical Laboratory Co Ltd SHE:301060	Diagnostics & Research	2.10%
Genoray Co. Ltd KQ:122310	Diagnostics & Research	0.03%
Bcal Diagnostics Ltd AU:BDX	Diagnostics & Research	0.00%
Avricore Health Inc V:AVCR	Diagnostics & Research	0.75%
Integral Diagnostics Ltd AU:IDX	Diagnostics & Research	0.03%

Annual Asset Resilience Ratio for Berry Genomics Co Ltd (1997–2024)

The table below shows the annual Asset Resilience Ratio data for Berry Genomics Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	0.71%	CN¥17.03 Million ≈ $2.49 Million	CN¥2.38 Billion ≈ $348.96 Million	+0.21pp
2023-12-31	0.51%	CN¥13.86 Million ≈ $2.03 Million	CN¥2.74 Billion ≈ $401.12 Million	+0.36pp
2022-12-31	0.14%	CN¥4.51 Million ≈ $659.26K	CN¥3.20 Billion ≈ $468.39 Million	+0.03pp
2021-12-31	0.11%	CN¥3.81 Million ≈ $558.25K	CN¥3.52 Billion ≈ $515.05 Million	-0.01pp
2020-12-31	0.12%	CN¥3.81 Million ≈ $558.25K	CN¥3.24 Billion ≈ $474.69 Million	-0.09pp
2019-12-31	0.21%	CN¥6.43 Million ≈ $940.91K	CN¥3.07 Billion ≈ $449.07 Million	-20.04pp
2016-12-31	20.25%	CN¥111.00 Million ≈ $16.24 Million	CN¥548.04 Million ≈ $80.20 Million	-29.86pp
2015-12-31	50.11%	CN¥250.00 Million ≈ $36.58 Million	CN¥498.88 Million ≈ $73.00 Million	+48.16pp
1998-12-31	1.95%	CN¥6.00 Million ≈ $877.99K	CN¥307.78 Million ≈ $45.04 Million	+0.22pp
1997-12-31	1.72%	CN¥5.00 Million ≈ $731.66K	CN¥289.91 Million ≈ $42.42 Million	--

pp = percentage points

About Berry Genomics Co Ltd

SHE:000710 China Diagnostics & Research

Market Cap

$516.80 Million

CN¥3.53 Billion CNY

Market Cap Rank

#12373 Global

#3840 in China

Share Price

CN¥9.99

Change (1 day)

+0.71%

52-Week Range

CN¥9.68 - CN¥16.61

All Time High

CN¥90.95